Antimicrobial treatment of lower respiratory tract infections in children

Area of Science:

• Pediatric Infectious Diseases
• Respiratory Medicine
• Clinical Microbiology

Background:

• Lower respiratory tract infections (LRTI), including pneumonia, are a significant cause of childhood illness and antibiotic prescriptions.
• Most LRTIs are viral and self-limiting, posing diagnostic challenges for clinicians, especially in febrile children.
• The bacterial epidemiology of pneumonia has shifted following the introduction of pneumococcal conjugate vaccine 13 (PCV13).

Purpose of the Study:

• To review the diagnosis and management of pneumonia in children.
• To discuss the evolving bacterial epidemiology of pediatric pneumonia and empyema.
• To align therapeutic recommendations with current French guidelines.

Main Methods:

• Review of clinical diagnostic approaches for pediatric pneumonia, including anamnesis, clinical examination, and imaging (chest X-ray, ultrasound).
• Analysis of biological markers in pneumonia diagnosis.
• Examination of updated bacterial epidemiology data, particularly concerning Streptococcus pneumoniae resistance patterns post-PCV13 implementation.
• Comparison of therapeutic strategies with official French recommendations.

Main Results:

• Pneumonia diagnosis relies on clinical evaluation, imaging, and biological markers.
• PCV13 has altered the bacterial landscape of pneumonia and empyema, reducing pneumococcal involvement.
• Antibiotic resistance, specifically penicillin and amoxicillin resistance in pneumococcal strains from blood cultures in children, remains very low (6% in 2021).

Conclusions:

• Diagnosis of pediatric pneumonia requires a multi-faceted approach.
• The epidemiology of bacterial pneumonia has been influenced by vaccination, leading to decreased pneumococcal prevalence.
• Current French recommendations for therapeutic choices are consistent with the observed low levels of antibiotic resistance.